InsiderClue
Stocks · Health care · Pharmaceutical Preparations

BridgeBio Pharma, Inc.

BBIO Clue Score39
United States Fiscal year ends December CIK 0001743881
$65.35 +0.48% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $65.35 +40.12% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 27 Jun 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−43.9Net income−43.8Fiscal year 2018Operating income−183.7Net income−169.5Fiscal year 2019Revenue40.6Operating income−266.2Net income−288.6Fiscal year 2020Revenue8.2 −79.7%Operating income−474.5Net income−505.5EPS, diluted−3.80Fiscal year 2021Revenue69.7 +745.1%Operating income−576.6Net income−586.5EPS, diluted−3.90Fiscal year 2022Revenue77.6 +11.4%Operating income−512.2Net income−484.7EPS, diluted−3.26Fiscal year 2023Revenue9.3 −88.0%Operating income−607.4Net income−653.3EPS, diluted−3.95Fiscal year 2024Revenue221.9 +2,285.3%Operating income−593.0Net income−543.3EPS, diluted−2.88Fiscal year 2025Revenue502.1 +126.3%Operating income−523.4Net income−732.9EPS, diluted−3.78
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 40.6 8.2 69.7 77.6 9.3 221.9 502.1
Growth −79.7% +745.1% +11.4% −88.0% +2,285.3% +126.3%
Operating income −43.9 −183.7 −266.2 −474.5 −576.6 −512.2 −607.4 −593.0 −523.4
Net income −43.8 −169.5 −288.6 −505.5 −586.5 −484.7 −653.3 −543.3 −732.9
Growth
EPS, diluted n/a n/a n/a −3.80 −3.90 −3.26 −3.95 −2.88 −3.78
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Fiscal year 2018Fiscal year 2019Operating margin−656.4%Net margin−711.5%Free cash flow margin−631.7%Fiscal year 2020Operating margin−5,752.0%Net margin−6,127.9%Free cash flow margin−4,936.7%Fiscal year 2021Operating margin−827.1%Net margin−841.2%Free cash flow margin−733.2%Fiscal year 2022Operating margin−659.6%Net margin−624.2%Free cash flow margin−546.5%Fiscal year 2023Operating margin−6,528.8%Net margin−7,021.9%Free cash flow margin−5,686.6%Fiscal year 2024Operating margin−267.2%Net margin−244.9%Free cash flow margin−235.1%Fiscal year 2025Operating margin−104.2%Net margin−146.0%Free cash flow margin−89.0%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −656.4% −5,752.0% −827.1% −659.6% −6,528.8% −267.2% −104.2%
Net margin n/a n/a −711.5% −6,127.9% −841.2% −624.2% −7,021.9% −244.9% −146.0%
Free cash flow margin n/a n/a −631.7% −4,936.7% −733.2% −546.5% −5,686.6% −235.1% −89.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−40.5Capital expenditure−0.5Free cash flow−41.0Dividends paid−1.2Fiscal year 2018Operating cash flow−136.6Capital expenditure−2.2Free cash flow−138.8Fiscal year 2019Operating cash flow−253.6Capital expenditure−2.6Free cash flow−256.2Dividends paid−1.0Fiscal year 2020Operating cash flow−399.7Capital expenditure−7.5Free cash flow−407.2Buybacks−75.0Fiscal year 2021Operating cash flow−497.9Capital expenditure−13.2Free cash flow−511.2Buybacks−200.0Fiscal year 2022Operating cash flow−419.5Capital expenditure−4.8Free cash flow−424.3Buybacks0.0Fiscal year 2023Operating cash flow−527.7Capital expenditure−1.3Free cash flow−529.0Buybacks0.0Fiscal year 2024Operating cash flow−520.7Capital expenditure−0.9Free cash flow−521.7Buybacks0.0Fiscal year 2025Operating cash flow−445.9Capital expenditure−1.1Free cash flow−447.0Buybacks−48.3
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −40.5 −136.6 −253.6 −399.7 −497.9 −419.5 −527.7 −520.7 −445.9
Capital expenditure −0.5 −2.2 −2.6 −7.5 −13.2 −4.8 −1.3 −0.9 −1.1
Free cash flow −41.0 −138.8 −256.2 −407.2 −511.2 −424.3 −529.0 −521.7 −447.0
Growth
Buybacks n/a n/a n/a −75.0 −200.0 0.0 0.0 0.0 −48.3
Dividends paid −1.2 n/a −1.0 n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash92.0Shareholders’ equity85.9Fiscal year 2018Cash436.1Total debt54.5Net cash (debt)381.6Shareholders’ equity314.9Debt to equity0.17Fiscal year 2019Cash363.8Total debt91.8Net cash (debt)272.0Shareholders’ equity408.5Debt to equity0.22Fiscal year 2020Cash356.1Total debt93.9Net cash (debt)262.2Shareholders’ equity57.9Debt to equity1.62Fiscal year 2021Cash393.8Total debt430.8Net cash (debt)−37.0Shareholders’ equity−870.4Fiscal year 2022Cash376.7Total debt431.0Net cash (debt)−54.3Shareholders’ equity−1,254.6Fiscal year 2023Cash375.9Total debt446.4Net cash (debt)−70.5Shareholders’ equity−1,354.3Fiscal year 2024Cash681.1Total debt437.3Net cash (debt)243.8Shareholders’ equity−1,467.9Fiscal year 2025Cash570.1Total debt2,007.3Net cash (debt)−1,437.2Shareholders’ equity−2,086.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 92.0 436.1 363.8 356.1 393.8 376.7 375.9 681.1 570.1
Total debt n/a 54.5 91.8 93.9 430.8 431.0 446.4 437.3 2,007.3
Net cash (debt) n/a 381.6 272.0 262.2 −37.0 −54.3 −70.5 243.8 −1,437.2
Shareholders’ equity 85.9 314.9 408.5 57.9 −870.4 −1,254.6 −1,354.3 −1,467.9 −2,086.6
Debt to equity n/a 0.17 0.22 1.62 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a 40.6 8.2 69.7 77.6 9.3 221.9 502.1
Growth −79.7% +745.1% +11.4% −88.0% +2,285.3% +126.3%
n/a n/a n/a n/a 3.1 3.4 2.4 3.9 21.0
30.6 140.1 209.9 337.0 451.0 399.5 455.7 506.5 452.0
13.3 43.6 94.4 145.7 192.2 143.2 150.6 288.9 531.2
−43.9 −183.7 −266.2 −474.5 −576.6 −512.2 −607.4 −593.0 −523.4
Growth
43.8 169.5 288.6 505.5 n/a −484.7 −653.3 −542.2 −732.5
n/a n/a n/a n/a n/a 0.0 0.0 1.2 0.4
−43.8 −169.5 −288.6 −505.5 −586.5 −484.7 −653.3 −543.3 −732.9
Growth
Per share
n/a n/a n/a −3.80 −3.90 −3.26 −3.95 −2.88 −3.78
n/a n/a n/a −3.80 −3.90 −3.26 −3.95 −2.88 −3.78
Growth
n/a n/a n/a 118.0 144.4 147.5 162.8 186.1 191.5
n/a n/a n/a 118.0 144.4 147.5 162.8 186.1 191.5
Growth +22.3% +2.2% +10.4% +14.3% +2.9%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 127.4% a year over five years.
  • The diluted share count rose 62.3% in five years, which is dilution.
  • Operating margin is up 5,647.7 points on five years ago, at -104.2%.
  • A net loss in 9 of 9 years on file.